CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice

Transplant Immunology

Volumn 19, Issue 3-4, 2008, Pages 197-201

  Yang, Dao Feng ^a   Qiu, Wen Hong ^b   Zhu, Hui Fen ^a   Lei, Ping ^a   Wen, Xue ^a   Dai, Hong ^a   Zhou, Wei ^a   Shen, Guan Xin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JIANGHAN UNIVERSITY   (China)

Author keywords

CTLA4 Ig; Dendritic cell; IDDM; Immune tolerance; Islet transplantation

Indexed keywords

ABATACEPT; GAMMA INTERFERON; GLUCOSE; IMMUNOGLOBULIN G1; INTERLEUKIN 4; MITOMYCIN C;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KIDNEY CAPSULE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; BLOOD GLUCOSE; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNIZATION; IMMUNOCONJUGATES; INTERFERON-GAMMA; INTERLEUKIN-4; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; STREPTOZOCIN; TH1 CELLS; TH2 CELLS; TRANSFECTION; TRANSGENES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 48149087253     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.05.005     Document Type: Article

References (28)

1. Ryan E.A., Lakey J.B., Paty B.W., Imes S., Korbutt G.S., Kneteman N.M., et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51 7 (2002) 2148-2157
2. Saito H., Frleta D., Dubsky P., and Palucka A.K. Dendritic cell-based vaccination against cancer. Hematol Oncol Clin North Am 20 3 (2006) 689-710
3. Buonocore S., Flamand V., Goldman M., and Braun M.Y. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Transplantation 75 3 (2003) 407-413
4. Thomson A.W., and Lu L. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 68 1 (1999) 1-8
5. Novak N. Targeting dendritic cells in allergen immunotherapy. Immunol Allergy Clin North Am 26 2 (2006) 307-319
6. Munz C., Steinman R.M., and Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 202 2 (2005) 203-207
7. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194 6 (2001) 863-869
8. Gong N., Pleyer U., Yang J., Vogt K., Hill M., Anegon I., et al. Influence of local and systemic CTLA4-Ig gene transfer on corneal allograft survival. J Gene Med 8 4 (2006) 459-467
9. Luo G., Wu J., Chen X., He W., Yi S., Xie Z., et al. CTLA4-Ig introduced by adenovirus vector locally to prolong the survival of xenogeneic skin grafts on rat burn wounds. J Trauma 59 5 (2005) 1209-1215
10. Schmitz V., Neumann U.P., Fischer U., Langrehr J., and Neuhaus P. Induction of long-term graft acceptance by a combination treatment of donor splenocytes and CTLA4-Ig in a high responder rat liver transplantation model. Transpl Int 18 10 (2005) 1187-1196
11. Potiron N., Chagneau C., Boeffard F., Soulillou J.P., Anegon I., and Le Mauff B. Adenovirus-mediated CTLA4-Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression. Cell Transplant 14 5 (2005) 263-275
12. Gabra B.H., and Sirois P. Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides 24 8 (2003) 1131-1139
13. Salgame P., Varadhachary A.S., Primiano L.L., Fincke J.E., Muller S., and Monestier M. An ELISA for detection of apoptosis. Nucleic Acids Res 25 3 (1997) 680-681
14. Linetsky E., Bottino R., Lehmann R., Alejandro R., Inverardi L., and Ricordi C. Improved human islet isolation using a new enzyme blend liberase. Diabetes 46 7 (1997) 1120-1123
15. Osorio R.W., Ascher N.L., Melzer J.S., and Stock P.G. [Beta]2-microglobulin gene disruption prolongs murine islet allograft survival in NOD mice. Transplant Proc 26 7 (1994) 752
16. Bertera1 S., Crawford M.L., Alexander A.M., Papworth G.D., Watkins S.C., Robbins P.D., et al. Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes 52 2 (2003) 387-393
17. Tatarkiewicz K., Hollister-Lock J., Quickel R.R., Colton C.K., Bonner-Weir S., and Weir G.C. Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islet. Transplantation 67 5 (1999) 665-671
18. Reijonen H., Mallone R., Heninger A.K., Laughlin E.M., Kochik S.A., Falk B., et al. GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 53 8 (2004) 1987-1994
19. Yoon J.W., Yoon C.S., Lim H.W., Huang Q.Q., Kang Y., Pyun K.H., et al. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β cells. Science 284 5417 (1999) 1183-1187
20. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109 1 (2002) 131-140
21. Loke P., and Allison J.P. Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells. Arthritis Res Ther 6 5 (2004) 208-214
22. Borriello F., Sethna M.P., Boyd S.D., Schweitzer A.N., Tivol E.A., Jacoby D., et al. B7-1 and B7-2 have overlapping,critical roles in immunoglobulin class switching and germinal center formation. Immunity 6 3 (1997) 303-313
23. Zhu M., Wei M.F., Liu F., Shi H.F., and Wang G. Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival. World J Gastroenterol 9 11 (2003) 2509-2512
24. Takayama T., Kaneko K., Morelli A.E., Li W., Tahara H., and Thomson A.W. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival. Transplantation 74 1 (2002) 112-119
25. Takayama T., Nishioka Y., Lu L., Lotze M.T., Tahara H., and Thomson A.W. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 66 12 (1998) 1567-1574
26. Seung E., Mordes J.P., Greiner D.L., and Rossini A.A. Induction of tolerance for islet transplantation for type 1 diabetes. Curr Diab Rep 3 4 (2003) 329-335
27. Gao W., Demirci G., and Li X.C. Negative T cell costimulation and islet tolerance. Diabetes Metab Res Rev 19 3 (2003) 179-185
28. Bykovskaia S.N., Shurin G.V., Graner S., Bunker M.L., Olson W., Thomas R., et al. Differentiation of immunostimulatory stem cell and monocyte-derived dendritic cells involves maturation of intracellular compartments responsible for antigen presentation and secretion. Stem Cells 20 5 (2002) 380-393